Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ganeden Obtains U.S. Patent - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Ganeden Obtains U.S. Patent

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Ganeden Biotech has obtained U.S. patent #8,697,055 B2, which protects the use of all Bacillus coagulans probiotic strains such as GanedenBC30, in coffee, tea and cereal applications.

Bacillus coagulans probiotics have the ability to withstand harsh manufacturing processes, especially those required to make hot tea, coffee and cereal. The effectiveness of these organisms can be linked to a naturally occurring layer of organic material (spore), which protects the genetic core of the bacteria throughout the manufacturing process and transit into the gut.

“This patent goes a long way toward supporting our partners in their quest to launch new brands, and revolutionize existing ones,” said Andy Lefkowitz, CEO of Ganeden Biotech. “When combined with the FDA’s No Objection letter on GRAS (safety), 17 studies published in peer reviewed journals, more than 100 patents issued around the world and the pending issuance of the first monograph by the USP, we have again demonstrated our commitment to science-based probiotic innovation.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters